Found: 18
Select item for more details and to access through your institution.
Chimeric Antigen Receptor T-Cell Postinfusion Fever: Infection Profile, Clinical Parameters, and Biomarkers Trends to Assist Antibiotic Stewardship.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae398
- By:
- Publication type:
- Article
Evaluation of cell collection efficiency in non‐mobilized adult donors for autologous chimeric antigen receptor T‐cell manufacturing.
- Published in:
- Vox Sanguinis, 2023, v. 118, n. 3, p. 217, doi. 10.1111/vox.13394
- By:
- Publication type:
- Article
Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1005457
- By:
- Publication type:
- Article
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.855730
- By:
- Publication type:
- Article
The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1649, doi. 10.1111/bjh.19348
- By:
- Publication type:
- Article
The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 525, doi. 10.1111/bjh.19170
- By:
- Publication type:
- Article
Is there a role for minimal residual disease monitoring in the management of patients with hairy‐cell leukaemia?
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 127, doi. 10.1111/bjh.14900
- By:
- Publication type:
- Article
Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 731, doi. 10.1002/ajh.26519
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2301, doi. 10.3390/cancers16132301
- By:
- Publication type:
- Article
CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4664, doi. 10.3390/cancers13184664
- By:
- Publication type:
- Article
Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 371, doi. 10.1111/ejh.14122
- By:
- Publication type:
- Article
Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's Transformation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.828471
- By:
- Publication type:
- Article
The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 6, p. 321, doi. 10.1177/2040620716671313
- By:
- Publication type:
- Article
The biology behind PI3K inhibition in chronic lymphocytic leukaemia.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 1, p. 25, doi. 10.1177/2040620714561581
- By:
- Publication type:
- Article
Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Manufacturing and Management of CAR T-Cell Therapy in "COVID-19's Time": Central Versus Point of Care Proposals.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.573179
- By:
- Publication type:
- Article
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1454, doi. 10.1093/jac/dkad105
- By:
- Publication type:
- Article
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article